CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: A novel hyaluronic acid-based drug delivery system

Chemical Biology and Drug Design

Volumn 83, Issue 6, 2014, Pages 741-752

  Goodarzi, Navid ^a   Ghahremani, Mohammad H ^a   Amini, Mohsen ^a   Atyabi, Fatemeh ^a   Ostad, Seyed N ^a   Shabani Ravari, Nazanin ^a   Nateghian, Navid ^a   Dinarvand, Rassoul ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

cancer stem cells; conjugation; macromolecular drug delivery; polysaccharides; prodrugs

Indexed keywords

DOCETAXEL; HERMES ANTIGEN; HYALURONIC ACID; TAXOID; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STEM CELL; CELL CYCLE ARREST; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG UPTAKE; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MORTALITY; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; BREAST NEOPLASMS; CHEMISTRY; FEMALE; METABOLISM; SOLUBILITY; TUMOR CELL LINE;

MUS;

ANTIGENS, CD44; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; HYALURONIC ACID; SOLUBILITY; TAXOIDS; WATER;

EID: 84901234041     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12288     Document Type: Article

References (53)

1. Liu M.T., Huang W.T., Wang A.Y., Huang C.C., Huang C.Y., Chang T.H., Pi C.P., Yang H.H,. (2010) Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Support Care Cancer; 18: 1553-1564.
2. Rahbari N.N., Aigner M., Thorlund K., Mollberg N., Motschall E., Jensen K., Diener M.K., Büchler M.W., Koch M., Weitz J., (2010) Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology; 138: 1714-1726.
3. Boukaram C., Hannoun-Levi J.-M., (2010) Management of prostate cancer recurrence after definitive radiation therapy. Cancer Treat Rev; 36: 91-100.
4. Coley H.M., (2008) Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat Rev; 34: 378-390.
5. Lacerda L., Pusztai L., Woodward W.A., (2010) The role of tumor initiating cells in drug resistance of breast cancer: implications for future therapeutic approaches. Drug Resist Updat; 13: 99-108.
6. Nowell P.C., (1976) The clonal evolution of tumor cell populations. Science; 194: 23.
7. Park C.Y., Tseng D., Weissman I.L., (2008) Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Mol Ther; 17: 219-230.
8. Velasco-Velázquez M.A., Popov V.M., Lisanti M.P., Pestell R.G., (2011) The role of breast cancer stem cells in metastasis and therapeutic implications. Am J Pathol; 179: 2-11.
9. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S., (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell; 138: 645-659.
10. Huczynski A., (2012) Salinomycin-a new cancer drug candidate. Chem Biol Drug Des; 79: 235-238.
11. Liu Y., Lu W.-L., Guo J., Du J., Li T., Wu J.-W., Wang G.-L., Wang J.-C., Zhang X., Zhang Q., (2008) A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes. J Control Release; 129: 18-25.
12. Zhang Y., Zhang H., Wang X., Wang J., Zhang X., Zhang Q., (2012) The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Biomaterials; 33: 679-691.
13. Mosallaei N., Jaafari M.R., Hanafi-Bojd M.Y., Golmohammadzadeh S., Malaekeh-Nikouei B., (2013) Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations. J Pharm Sci; 102: 1994-2004.
14. Flygare J.A., Pillow T.H., Aristoff P., (2013) Antibody-drug conjugates for the treatment of cancer. Chem Biol Drug Des; 81: 113-121.
15. Ponti D., Zaffaroni N., Capelli C., Daidone M.G., (2006) Breast cancer stem cells: an overview. Eur J Cancer; 42: 1219-1224.
16. Karamboulas C., Ailles L., (2013) Developmental signaling pathways in cancer stem cells of solid tumors. Biochim Biophys Acta; 1830: 2481-2495.
17. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F., (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A; 100: 3983-3988.
18. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., Daidone M.G., (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res; 65: 5506-5511.
19. Fillmore C.M., Kuperwasser C., (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res; 10: R25.
20. Luo Y., Ziebell M.R., Prestwich G.D., (2000) A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules; 1: 208-218.
21. Toole B.P., (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer; 4: 528-539.
22. Mimeault M., Batra S., (2010) New advances on critical implications of tumor-and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence. Histol Histopathol; 25: 1057-1073.
23. Mimeault M., Hauke R., Batra S., (2007) Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin Pharmacol Ther; 83: 673-691.
24. Cichy J., Puré E., (2004) Cytokines regulate the affinity of soluble CD44 for hyaluronan. FEBS Lett; 556: 69-74.
25. Sherman L., Sleeman J., Herrlich P., Ponta H., (1994) Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol; 6: 726-733.
26. Gandhi N.S., Mancera R.L., (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des; 72: 455-482.
27. Goodarzi N., Varshochian R., Kamalinia G., Atyabi F., Dinarvand R., (2013) A review of polysaccharide cytotoxic drug conjugates for cancer therapy. Carbohydr Polym; 92: 1280-1293.
28. Turley E.A., Noble P.W., Bourguignon L.Y.W., (2002) Signaling properties of hyaluronan receptors. J Biol Chem; 277: 4589-4592.
29. Götte M., Yip G.W., (2006) Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res; 66: 10233-10237.
30. Goodarzi N., Ghahremani M.H., Dinarvand R., (2011) Targeting CD44 by hyaluronic acid-based nano drug delivery systems may eradicate cancer stem cells in human breast cancer. J Med Hypotheses Ideas; 5: 26-30.
31. Duncan R., Richardson S.C., (2012) Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges. Mol Pharm; 9: 2380-2402.
32. Wang X., Tu Q., Zhao B., An Y., Wang J.-C., Liu W., Yuan M.-S., Ahmed S.M., Xu J., Liu R., Zhang Y., Wang J., (2013) Effects of poly(l-lysine)- modified Fe3O4 nanoparticles on endogenous reactive oxygen species in cancer stem cells. Biomaterials; 34: 1155-1169.
33. Burke A.R., Singh R.N., Carroll D.L., Wood J.C.S., D'Agostino R.B. Jr, Ajayan P.M., Torti F.M., Torti S.V., (2012) The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials; 33: 2961-2970.
34. Stratford E.W., Bostad M., Castro R., Skarpen E., Berg K., Høgset A., Myklebost O., Selbo P.K., (2013) Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity. Biochim Biophys Acta; 1830: 4235-4243.
35. Luo Y., Prestwich G.D., (1999) Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem; 10: 755-763.
36. Cao N., Feng S.-S., (2008) Doxorubicin conjugated to d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials; 29: 3856-3865.
37. Oh E.J., Park K., Kim K.S., Kim J., Yang J.-A., Kong J.-H., Lee M.Y., Hoffman A.S., Hahn S.K., (2010) Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release; 141: 2-12.
38. Banerji S., Wright A.J., Noble M., Mahoney D.J., Campbell I.D., Day A.J., Jackson D.G., (2007) Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat Struct Mol Biol; 14: 234-239.
39. Nam K., Kimura T., Kishida A., (2008) Controlling coupling reaction of EDC and NHS for preparation of collagen gels using ethanol/water co-solvents. Macromol Biosci; 8: 32-37.
40. Schanté C.E., Zuber G., Herlin C., Vandamme T.F., (2011) Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr Polym; 85: 469-489.
41. Charlot A., Heyraud A., Guenot P., Rinaudo M., Auzely-Velty R., (2006) Controlled synthesis and inclusion ability of a hyaluronic acid derivative bearing beta-cyclodextrin molecules. Biomacromolecules; 7: 907-913.
42. Esmaeili F., Dinarvand R., Ghahremani M.H., Amini M., Rouhani H., Sepehri N., Ostad S.N., Atyabi F., (2009) Docetaxel-albumin conjugates: preparation, in vitro evaluation and biodistribution studies. J Pharm Sci; 98: 2718-2730.
43. Lee E., Kim H., Lee I.-H., Jon S., (2009) In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. J Control Release; 140: 79-85.
44. Luo Y., Kirker K.R., Prestwich G.D., (2000) Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Release; 69: 169-184.
45. Tzircotis G., Thorne R.F., Isacke C.M., (2005) Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci; 118: 5119-5128.
46. Surace C., Arpicco S., Dufay-Wojcicki A., Marsaud V., Bouclier C., Clay D., Cattel L., Renoir J.M., Fattal E., (2009) Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol Pharm; 6: 1062-1073.
47. Nehme A., Varadarajan P., Sellakumar G., Gerhold M., Niedner H., Zhang Q., Lin X., Christen R.D., (2001) Modulation of docetaxel-induced apoptosis and cell cycle arrest by all- trans retinoic acid in prostate cancer cells. Br J Cancer; 84: 1571-1576.
48. Chen J., Sun W.L., Wasylyk B., Wang Y.P., Zheng H., (2012) c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells. Anticancer Drugs; 23: 98-107.
49. Amiral J., Meyer D., (1998) 12 Heparin-induced thrombocytopenia: diagnostic tests and biological mechanisms. Baillieres Clin Haematol; 11: 447-460.
50. Osmers R.G.W., Schütz E., Diedrich F., Wehry B., Krauβ T., Oellerich M., Kuhn W., (1998) Increased serum levels of hyaluronic acid in pregnancies complicated by preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Obstet Gynecol; 178: 341-345.
51. Svensson Holm A.-C.B., Bengtsson T., Grenegård M., Lindström E.G., (2012) Hyaluronic acid influence on platelet-induced airway smooth muscle cell proliferation. Exp Cell Res; 318: 632-640.
52. Koshiishi I., Shizari M., Underhill C.B., (1994) CD44 can mediate the adhesion of platelets to hyaluronan. Blood; 84: 390-396.
53. Platt V.M., Szoka F.C. Jr, (2008) Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm; 5: 474-486.